NCT05532865 Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking
| NCT ID | NCT05532865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Brest |
| Condition | Systemic Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-10-13 |
| Primary Completion | 2032-10-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-10-13 with a primary completion date of 2032-10-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study corresponds to a monocentric prospective cohort of adult patients with systemic sclerosis. It will allow the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood samples, as well as stool sample and skin swab for microbiota analysis.
Eligibility Criteria
Inclusion Criteria: * Major patient with systemic sclerosis defined according to the EULAR 2013 criteria (see Appendix 1) * Patient evaluated within the framework of the reference center for rare autoimmune diseases of the CHU of Brest. * Patient affiliated to the social security system * Patient having signed a written informed consent. Exclusion Criteria: * Minor * Patient under legal protection (guardianship, curatorship) * Refusal to participate * Patient unable to consent * Pregnant or breastfeeding woman * Hemoglobin (Hb) level \< 7g/dl
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05532865 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Systemic Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05532865 currently recruiting?
Yes, NCT05532865 is actively recruiting participants. Contact the research team at claire.demoreuil@chu-brest.fr for enrollment information.
Where is the NCT05532865 trial being conducted?
This trial is being conducted at Brest, France.
Who is sponsoring the NCT05532865 clinical trial?
NCT05532865 is sponsored by University Hospital, Brest. The trial plans to enroll 100 participants.